From October 2016 to February 2018, 1,428 naloxone kits were distributed to 1,399 people being released from Allegheny County Jail, some multiple times. Large numbers were distributed to people living in areas with particularly high opioid overdose rates, according to a report published by the county at the end of February. Naloxone, often known by the brand name Narcan, reverses overdoses and has been central to declining overdose deaths since 2017.
Not all jail dischargees who took kits live in neighborhoods or municipalities with particularly high overdose rates — Downtown Pittsburgh tops the list — but many of them did. Carrick, the epicenter of the local opioid epidemic, was the city's second biggest home to naloxone recipients.
Outside the city, Ross, North Versailles and West Mifflin are among the municipalities with high overdose rates that were home to many people who received naloxone on discharge from the jail.
“We were excited when we saw this map — we wanted to help those communities that have the greatest need,” said Laura Williams, the jail’s chief deputy warden for health care services.
Nearly half of the people in Allegheny County who died of opioid-related overdose deaths from 2015 to 2016 had previously spent time at the county jail, according to another report released by the county in early 2018. Sparked by statistics like that, the jail began offering the kits with the overdose-reversing drug naloxone to people being released into the community in October 2016.
“We had a large increase in meeting an at-risk population, but obviously we unfortunately did have a large group that died,” Ms. Williams said.
Overdose risks are particularly high immediately after release, according to the study.
Among people who accepted the naloxone kit in the study period, 21, or 1.5 percent, died of an overdose by January 2019, the report said. The study has no direct comparison number for non-recipients but points out that the two populations are likely to have different risk levels. For example, slightly less than half of recipients had been through detox services at the jail, versus 18 percent of the jail population.
Alice Bell, who coordinates naloxone distribution for Prevention Point Pittsburgh, a nonprofit that provides sterile injection equipment, noted that the population that has gone through detox is only a subset of the drug-using population — it's only those who are dependent when they are arrested.
“Lots and lots of people who use drugs aren’t dependent. That’s an important component,” she said.
While some half of detox recipients did not take the kit, Ms. Bell said, “I don’t think that means you’re not reaching the right population.”
Naloxone isn’t self-administered, but it is still most likely to be useful to drug users, Ms. Bell said.
“People who use drugs are more likely to be around other people who do,” she said.
Ms. Bell said her organization had long encouraged the jail to offer naloxone on release.
“We are very supportive of the jail doing that,” she said.
In addition to including a large number of people who have been through detox, the population that took naloxone on release was more female and older than the broader jail population, the report says.
The county medical examiner has yet to publish final numbers for 2018, but it is expected that they will show a significant drop in the opioid-related overdose rate versus 2017. According to Ms. Bell, the increasing saturation of naloxone has contributed to that decline.
“In places that have done a really good job of saturating the opiate-using community with naloxone, they have seen a drop in overdose deaths,” she said. “We see people who report that they’ve got naloxone from the jail.”
Among people who use Prevention Point’s clean syringe services, the vast majority have naloxone kits, Ms. Bell said.
Ms. Williams said there has been a slight decline in naloxone acceptance at the jail, which she attributed to some staffing issues at the jail limiting the amount of time they can spend pitching naloxone during discharge procedures.
Sometimes it can be hard to persuade people who have detoxed in the jail to take the kit, as it might feel like admitting defeat, she explained.
But Ms. Bell points out that the surgeon general encourages everyone to carry naloxone, regardless of their drug usage or non-usage.
“The way you counter that is by saying this isn’t about you, you aren’t going to use it on you. This is just you being a good citizen that might save a life,” she said.
Christopher Huffaker: 412-263-1724, chuffaker@post-gazette.com, or @huffakingit.






Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.